[1] |
Gao J, Song Z, Chen Y, et al. Deregulated of Notch receptors in human hepatocellular carcinoma[J]. Dig Liver Dis, 2008, 40(2): 114⁃121. DOI: 10.1016/j.dld.2007.08.001.
|
[2] |
Gramantieri L, Giovannini C, Lanzi A, et al. Aberrant Notch3 and Notch4 in human hepatocellular carcinoma[J]. Liver Int, 2007, 27(7): 997⁃1007. DOI: 10.1111/j.1478⁃3231.2007. 01544.x.
|
[3] |
Konishi J, Kawaguchi KS, Vo H, et al. Gamma⁃secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers[J]. Cancer Res, 2007, 67(17): 8051⁃8057. DOI: 10.1158/0008⁃5472.CAN⁃07⁃1022.
|
[4] |
Donnem T, Andersen S, Al⁃Shibli K, et al. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: co of Notch⁃1 and vascular endothelial growth factor⁃A predicts poor survival[J]. Cancer, 2010, 116(24): 5676⁃5685. DOI: 10.1002/cncr.25551.
|
[5] |
Chen J, Imanaka N, Chen J, et al. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E⁃cadherin and increased cell migration and invasion[J]. Br J Cancer, 2010, 102(2): 351⁃360. DOI: 10.1038/sj.bjc.6605486.
|
[6] |
Peng GL, Tian Y, Lu C, et al. Effects of Notch⁃1 down⁃regulation on malignant behaviors of breast cancer stem cells[J]. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(2): 195⁃200. DOI: 10.1007/s11596⁃014⁃1258⁃4.
|
[7] |
Brzozowa M, Mielańczyk L, Michalski M, et al. Role of Notch signaling pathway in gastric cancer pathogenesis[J]. Contemp Oncol (Pozn), 2013, 17(1): 1⁃5. DOI: 10.5114/wo.2013.33765.
|
[8] |
Nowell C, Radtke F. Cutaneous Notch signaling in health and disease[J]. Cold Spring Harb Perspect Med, 2013, 3(12): a017772. DOI: 10.1101/cshperspect.a017772.
|
[9] |
South AP, Purdie KJ, Watt SA, et al. NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis[J]. J Invest Dermatol, 2014, 134(10): 2630⁃2638. DOI: 10.1038/jid.2014.154.
|
[10] |
Massi D, Tarantini F, Franchi A, et al. Evidence for differential of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma[J]. Mod Pathol, 2006, 19(2): 246⁃254. DOI: 10.1038/modpathol.3800526.
|
[11] |
吴琼, 李阿梅, 邵雪宝, 等. 甲苯胺蓝染色在黑素瘤免疫组化复染中的应用[J]. 临床与实验病理学杂志, 2015, (8): 941⁃942. DOI: 10.13315/j.cnki.cjcep.2015.08.029.
|
[12] |
Murtas D, Piras F, Minerba L, et al. Activated Notch1 is associated with angiogenesis in cutaneous melanoma[J]. Clin Exp Med, 2015, 15(3): 351⁃360. DOI: 10.1007/s10238⁃014⁃0300⁃y.
|
[13] |
Qiu H, Tang X, Ma J, et al. Notch1 autoactivation via transcriptional regulation of furin, which sustains Notch1 signaling by processing Notch1⁃activating proteases ADAM10 and membrane type 1 matrix metalloproteinase[J]. Mol Cell Biol, 2015, 35(21): 3622⁃3632. DOI: 10.1128/MCB.00116⁃15.
|
[14] |
Basak A, Chen A, Scamuffa N, et al. Blockade of furin activity and furin⁃induced tumor cells malignant phenotypes by the chemi⁃cally synthesized human furin prodomain[J]. Curr Med Chem, 2010, 17(21): 2214⁃2221. DOI: 10.2174/092986710791331040.
|
[15] |
Hardy KM, Kirschmann DA, Seftor EA, et al. Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype[J]. Cancer Res, 2010, 70(24): 10340⁃10350. DOI: 10.1158/0008⁃5472.CAN⁃10⁃0705.
|
[16] |
Bedogni B. Notch signaling in melanoma: interacting pathways and stromal influences that enhance Notch targeting[J]. Pigment Cell Melanoma Res, 2014, 27(2): 162⁃168. DOI: 10.1111/pcmr. 12194.
|
[17] |
Kirschmann DA, Seftor EA, Hardy KM, et al. Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications[J]. Clin Cancer Res, 2012, 18(10): 2726⁃2732. DOI: 10.1158/1078⁃0432.CCR⁃11⁃3237.
|
[18] |
Qiu XX, Chen L, Wang CH, et al. The vascular notch ligands delta⁃like ligand 4 (DLL4) and Jagged1 (JAG1) have opposing correlations with microvascularization but a uniform prognostic effect in primary glioblastoma: a preliminary study[J]. World Neurosurg, 2016, 88: 447⁃458. DOI: 10.1016/j.wneu.2015.10. 058.
|
[19] |
Pedrosa AR, Trindade A, Fernandes AC, et al. Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1[J]. Arterioscler Thromb Vasc Biol, 2015, 35(5): 1134⁃1146. DOI: 10.1161/ATVBAHA.114.304741.
|
[20] |
Benedito R, Rocha SF, Woeste M, et al. Notch⁃dependent VEGFR3 upregulation allows angiogenesis without VEGF⁃VEGFR2 signal⁃ling[J]. Nature, 2012, 484(7392): 110⁃114. DOI: 10.1038/nature10908.
|
[21] |
Siekmann AF, Affolter M, Belting HG. The tip cell concept 10 years after: new players tune in for a common theme[J]. Exp Cell Res, 2013, 319(9): 1255⁃1263. DOI: 10.1016/j.yexcr.2013.01. 019.
|
[22] |
Zhang J, Ye J, Ma D, et al. Cross⁃talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway[J]. Carcinogenesis, 2013, 34(3): 667⁃677. DOI: 10.1093/carcin/bgs386.
|